SEC Comment Letter 0000000000-23-011868 to CONTRAFECT Corp (CFRXQ) (CIK 0001478069)
CONTRAFECT Corp (CFRXQ) (CIK 0001478069)
Date: Oct. 30, 2023 · CIK: 0001478069 · Accession: 0000000000-23-011868
AI Filing Summary & Sentiment
File numbers found in text: 333-275148
Letter
United States securities and exchange commission logo October 30, 2023 Natalie Bogdanos, Esq. General Counsel and Corporate Secretary ContraFect Corporation 28 Wells Avenue, Third Floor Yonkers, New York 10701 Re:ContraFect Corporation Registration Statement on Form S-1 Filed October 24, 2023 File No. 333-275148 Dear Natalie Bogdanos: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Wesley C. Holmes, Esq.
Show Raw Text
United States securities and exchange commission logo
October 30, 2023
Natalie Bogdanos, Esq.
General Counsel and Corporate Secretary
ContraFect Corporation
28 Wells Avenue, Third Floor
Yonkers, New York 10701
Re:ContraFect Corporation
Registration Statement on Form S-1
Filed October 24, 2023
File No. 333-275148
Dear Natalie Bogdanos:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Wesley C. Holmes, Esq.